- Home
- NAAS vs CLNN Comparison
NAAS vs CLNN Comparison
Compare NAAS & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAAS
- CLNN
- Stock Information
- Founded
- NAAS 2019
- CLNN 2012
- Country
- NAAS China
- CLNN United States
- Employees
- NAAS N/A
- CLNN N/A
- Industry
- NAAS Other Specialty Stores
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- NAAS Consumer Discretionary
- CLNN Health Care
- Exchange
- NAAS Nasdaq
- CLNN Nasdaq
- Market Cap
- NAAS 40.1M
- CLNN 43.0M
- IPO Year
- NAAS 2017
- CLNN N/A
- Fundamental
- Price
- NAAS $2.91
- CLNN $4.53
- Analyst Decision
- NAAS
- CLNN Strong Buy
- Analyst Count
- NAAS 0
- CLNN 4
- Target Price
- NAAS N/A
- CLNN $59.25
- AVG Volume (30 Days)
- NAAS 141.1K
- CLNN 54.9K
- Earning Date
- NAAS 11-20-2024
- CLNN 11-13-2024
- Dividend Yield
- NAAS N/A
- CLNN N/A
- EPS Growth
- NAAS N/A
- CLNN N/A
- EPS
- NAAS N/A
- CLNN N/A
- Revenue
- NAAS $58,241,066.00
- CLNN $421,000.00
- Revenue This Year
- NAAS $19.53
- CLNN N/A
- Revenue Next Year
- NAAS $151.36
- CLNN $1,058.37
- P/E Ratio
- NAAS N/A
- CLNN N/A
- Revenue Growth
- NAAS 199.95
- CLNN N/A
- 52 Week Low
- NAAS $1.42
- CLNN $3.82
- 52 Week High
- NAAS $59.20
- CLNN $12.00
- Technical
- Relative Strength Index (RSI)
- NAAS 45.72
- CLNN 34.27
- Support Level
- NAAS $2.50
- CLNN $5.00
- Resistance Level
- NAAS $2.95
- CLNN $6.04
- Average True Range (ATR)
- NAAS 0.22
- CLNN 0.52
- MACD
- NAAS 0.01
- CLNN -0.17
- Stochastic Oscillator
- NAAS 56.10
- CLNN 8.80
About NAAS NaaS Technology Inc.
Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators. wide range of offline services that simplify the daily operations of charging station operators, and of non-charging services such as food and beverage services to station operators.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).